Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
OBSERVATIONAL
2013-02-28
2016-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effects of Exercise of Secreted Factors From Muscle and Adipose Tissue
NCT02565823
Effectiveness of Pulse-Based Foods Combined With Exercise for Improving Components of the Metabolic Syndrome
NCT00800033
Mitochondrial Dysfunction in Diabetes
NCT01724502
Effects of Fasted- Versus Fed-exercise on Metabolic Health in Physically Active Adults
NCT06949709
PGC-1 & Muscle Mitochondrial Dysfunction in Diabetes
NCT02282423
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Moderate Physical Exercise
This intervention is comprised of two separate visits at least one week apart. The purpose of visit 1 is to determine the cycle ergometer workload that produces a moderate exercise intensity of 60% heart rate reserve to be used on visit 2. The purpose of visit 2 is to determine changes in platelet reactivity in response to moderate exercise.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* BMI \>/=26 and \<40 kg/m2
* not planning to or currently attempting to gain or lose weight
* low reported omega-3 fatty acid intake per Omega-3 Checklist
* Metabolic Syndrome as define 3/5 of the following:Waist circumference: men \> 102 cm women \> 88 cm, triglycerides \> 150 mg/dL, HDL cholesterol: men \< 40 mg/dL women \< 50 mg/dL,Blood pressure \>130/\>85 mmHg,Fasting glucose \> 100 mg/dL (Hypertensive subjects are eligible if taking thiazide diuretics NOT ACE inhibitors beta blockers)
Exclusion Criteria
* take any medication that makes you unable to exercise
* have established cardiovascular, pulmonary, and/or metabolic disease such as diabetes
* have uncontrolled hypertension
* have alcohol, anabolic steroid, or other substance abuse issues
* consume more than 3 alcoholic drinks/week
* have joint or muscle injuries that affects your ability to exercise
* have cancer (other than skin cancer or carcinoma in situ of the cervix
* pregnant or lactating
* currently exercise regularly
* taking non-steroidal anti-inflammatory medications (aspirin, Aleve, Advil, ibuprofen, naproxen
* take lipid modifying medications such as statins (Lipitor, Zocor)
* take medications for blood glucose such as insulin or metformin
* take medications that affect platelet functions (Plavix)
* taking omega-3 supplements (fish or flax oil)
30 Years
60 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
USDA Grand Forks Human Nutrition Research Center
FED
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Matthew Picklo, PhD
Role: PRINCIPAL_INVESTIGATOR
USDA Grand Forks Human Nutrition Research Center
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
GFHNRC026
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.